Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D009316:National Institutes of Health (U.S.); D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011446:Prospective Studies; D014183:Transplantation, Heterologous; D014481:United States
D000970:Antineoplastic Agents